North Carolina Clinical Trials
Browse actively recruiting clinical trials with research sites in North Carolina. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in North Carolina
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisNCT06972446PHASE2AbbVieRheumatoid ArthritisCharlotte, NC
- Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialNCT06770582PHASE2National Cancer Institute (NCI)Non-Muscle Invasive Bladder Urothelial CarcinomaChapel Hill, NC
- LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisNCT07415044PHASE2Eli Lilly and CompanyUlcerative Colitis (UC)Greenville, NC
- A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian CancerNCT07059845PHASE2AbbVieOvarian CancerPinehurst, NC
- AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)NCT05850234PHASE1, PHASE2AstraZenecaRelapsed/Refractory Multiple MyelomaCharlotte, NC
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseNCT07011745PHASE3Bristol-Myers SquibbAlzheimer's DiseaseMorehead City, NC
- A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerNCT07100106PHASE1, PHASE2Genentech, Inc.Breast CancerCharlotte, NC
- ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerNCT07173751PHASE3BioNTech SEBreast NeoplasmsCharlotte, NC
- A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic MigraineNCT05711394PHASE3AbbVieEpisodic MigraineGreensboro, NC
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)NCT06393374PHASE3Merck Sharp & Dohme LLCTriple-Negative Breast CancerCharlotte, NC
- A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell HistiocytosisNCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisAsheville, NC
- A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineNCT07816367PHASE3Kallyope Inc.MigraineCary, NC
Clinical trials by North Carolina metro
Popular conditions in North Carolina
Frequently asked questions
- How do I find clinical trials in North Carolina?
- Corterve aggregates actively recruiting clinical trials with sites in North Carolina from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in North Carolina free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in North Carolina?
- North Carolina research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.